Health
New drug reduces tumor volume and pain in patients with neurofibromatosis type 1 – News-Medical.Net
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).
The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
Noosa News9 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News21 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Noosa News22 hours agoSchools ban e-bikes | Noosa Today
-
Business24 hours agoMacquarie tips more than 20% upside for this ASX mining stock